Hycroft Mining Holding Corporation Class A Common Stock vs 10X Genomics Inc — how do they compare? Hycroft Mining Holding Corporation Class A Common Stock trades at $16.21 (market cap $1.52B), while 10X Genomics Inc trades at $70.04 (market cap $9.53B). The key difference: 10X Genomics Inc is far larger — about 6.3× Hycroft Mining Holding Corporation Class A Common Stock's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Hycroft Mining Holding Corporation Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hycroft Mining Holding Corporation Class A Common Stock for 0 Days and 10X Genomics Inc for 91 Days on average.
| HYMC | TXG | |
|---|---|---|
Market Cap | $1.52B | $9.53B |
Volume | 3,040,922 | 4,138,224 |
Sector | Basic Materials | Health |
52-Week High | $55.74 | $97.74 |
52-Week Low | $6.75 | $11.83 |
Typical Hold Time | 0 Days | 91 Days |
Enterprise Value | $1.30B | $9.05B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TXG trades at $71.79, down 4.52% on the day, amid a bearish technical signal. The company shows improving fundamentals with revenue of $642.82M in 2025 and a narrowing net loss of -$43.54M. Recent news highlights strong demand for its Atera spatial biology platform and a patent victory, though insider selling and high valuation ratios like a P/S of 15.13 and EV/EBITDA of 241.6 present concerns.
The outlook is mixed; analyst consensus is a Buy with a $83.30 price target, but execution risks on Atera delivery and sustained profitability remain key. Upside depends on commercial success of new platforms, while downside risks include competitive pressures and failure to achieve positive earnings.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hycroft Mining Holding Corporation is a US mining company that owns and operates the Hycroft Mine, a gold and silver deposit in northern Nevada, producing and selling gold and silver from open-pit mining operations.
Read more on HYMC →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →